Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C3,5 | Lung | Primary cancer | 2,395 | Stromal | 32.2% | 0.50 | 0.80 |
| NSCLC_38242124__IMC__88_C3,6 | Lung | Primary cancer | 3,905 | Immune | 27.3% | 0.51 | 0.78 |
| NSCLC_38242124__IMC__88_C3,7 | Lung | Primary cancer | 4,437 | Tumor/Malignant | 38.5% | 0.93 | 0.27 |
| NSCLC_38242124__IMC__88_C3,8 | Lung | Primary cancer | 2,655 | Stromal | 43.4% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__88_C3,9 | Lung | Primary cancer | 825 | Tumor/Malignant | 54.5% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_C4,1 | Lung | Primary cancer | 3,475 | Tumor/Malignant | 58.8% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__88_C4,10 | Lung | Primary cancer | 4,221 | Immune | 42.2% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__88_C4,11 | Lung | Primary cancer | 3,121 | Tumor/Malignant | 75.2% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__88_C4,13 | Lung | Primary cancer | 709 | Stromal | 38.5% | 0.81 | 0.45 |
| NSCLC_38242124__IMC__88_C4,14 | Lung | Primary cancer | 5,648 | Immune | 77.2% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_C4,15 | Lung | Primary cancer | 540 | Tumor/Malignant | 34.3% | 0.32 | 0.99 |
| NSCLC_38242124__IMC__88_C4,2 | Lung | Primary cancer | 2,398 | Tumor/Malignant | 59.9% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__88_C4,3 | Lung | Primary cancer | 2,635 | Tumor/Malignant | 59.5% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__88_C4,4 | Lung | Primary cancer | 392 | Stromal | 41.6% | 0.87 | 0.37 |
| NSCLC_38242124__IMC__88_C4,5 | Lung | Primary cancer | 2,537 | Stromal | 42.6% | 0.88 | 0.36 |
| NSCLC_38242124__IMC__88_C4,6 | Lung | Primary cancer | 2,515 | Tumor/Malignant | 46.7% | 0.99 | 0.08 |
| NSCLC_38242124__IMC__88_C4,7 | Lung | Primary cancer | 118 | Stromal | 53.4% | 0.44 | 0.76 |
| NSCLC_38242124__IMC__88_C4,8 | Lung | Primary cancer | 2,727 | Tumor/Malignant | 50.7% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__88_C4,9 | Lung | Primary cancer | 2,389 | Immune | 34.7% | 0.90 | 0.25 |
| NSCLC_38242124__IMC__88_C5,1 | Lung | Primary cancer | 3,087 | Stromal | 44.4% | 0.82 | 0.47 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C3,5 | Lung | Primary cancer | 2,395 | Stromal | 33.7% | 0.88 | 0.34 |
| NSCLC_38242124__IMC__88_C3,6 | Lung | Primary cancer | 3,905 | Lymphoid | 26.0% | 0.44 | 0.89 |
| NSCLC_38242124__IMC__88_C3,7 | Lung | Primary cancer | 4,437 | Tumor/Malignant | 39.7% | 0.93 | 0.28 |
| NSCLC_38242124__IMC__88_C3,8 | Lung | Primary cancer | 2,655 | Stromal | 28.2% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__88_C3,9 | Lung | Primary cancer | 825 | Tumor/Malignant | 44.8% | 0.97 | 0.06 |
| NSCLC_38242124__IMC__88_C4,1 | Lung | Primary cancer | 3,475 | Tumor/Malignant | 52.2% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__88_C4,10 | Lung | Primary cancer | 4,221 | Lymphoid | 41.2% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__88_C4,11 | Lung | Primary cancer | 3,121 | Tumor/Malignant | 62.8% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_C4,13 | Lung | Primary cancer | 709 | Stromal | 38.1% | 0.81 | 0.45 |
| NSCLC_38242124__IMC__88_C4,14 | Lung | Primary cancer | 5,648 | Lymphoid | 77.5% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_C4,15 | Lung | Primary cancer | 540 | Stromal | 45.7% | 0.54 | 0.83 |
| NSCLC_38242124__IMC__88_C4,2 | Lung | Primary cancer | 2,398 | Tumor/Malignant | 44.3% | 0.96 | 0.10 |
| NSCLC_38242124__IMC__88_C4,3 | Lung | Primary cancer | 2,635 | Tumor/Malignant | 44.2% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__88_C4,4 | Lung | Primary cancer | 392 | Stromal | 45.7% | 0.80 | 0.43 |
| NSCLC_38242124__IMC__88_C4,5 | Lung | Primary cancer | 2,537 | Stromal | 35.3% | 0.90 | 0.33 |
| NSCLC_38242124__IMC__88_C4,6 | Lung | Primary cancer | 2,515 | Tumor/Malignant | 52.7% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_C4,7 | Lung | Primary cancer | 118 | Tumor/Malignant | 62.7% | 0.74 | 0.49 |
| NSCLC_38242124__IMC__88_C4,8 | Lung | Primary cancer | 2,727 | Tumor/Malignant | 36.9% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__88_C4,9 | Lung | Primary cancer | 2,389 | Lymphoid | 28.9% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__88_C5,1 | Lung | Primary cancer | 3,087 | Stromal | 33.1% | 0.85 | 0.41 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C3,5 | Lung | Primary cancer | 2,395 | Fibroblast | 40.3% | 0.69 | 0.66 |
| NSCLC_38242124__IMC__88_C3,6 | Lung | Primary cancer | 3,905 | Fibroblast | 31.5% | 0.64 | 0.76 |
| NSCLC_38242124__IMC__88_C3,7 | Lung | Primary cancer | 4,437 | Tumor/Malignant cell | 42.7% | 0.93 | 0.32 |
| NSCLC_38242124__IMC__88_C3,8 | Lung | Primary cancer | 2,655 | Fibroblast | 41.5% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__88_C3,9 | Lung | Primary cancer | 825 | Tumor/Malignant cell | 52.0% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_C4,1 | Lung | Primary cancer | 3,475 | Tumor/Malignant cell | 60.6% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_C4,10 | Lung | Primary cancer | 4,221 | T cell | 41.4% | 0.51 | 0.59 |
| NSCLC_38242124__IMC__88_C4,11 | Lung | Primary cancer | 3,121 | Tumor/Malignant cell | 74.9% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__88_C4,13 | Lung | Primary cancer | 709 | Fibroblast | 40.1% | 0.77 | 0.52 |
| NSCLC_38242124__IMC__88_C4,14 | Lung | Primary cancer | 5,648 | B cell | 64.0% | 0.94 | 0.16 |
| NSCLC_38242124__IMC__88_C4,15 | Lung | Primary cancer | 540 | Fibroblast | 48.9% | 0.51 | 0.86 |
| NSCLC_38242124__IMC__88_C4,2 | Lung | Primary cancer | 2,398 | Tumor/Malignant cell | 61.6% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__88_C4,3 | Lung | Primary cancer | 2,635 | Tumor/Malignant cell | 65.0% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__88_C4,4 | Lung | Primary cancer | 392 | Fibroblast | 45.7% | 0.83 | 0.44 |
| NSCLC_38242124__IMC__88_C4,5 | Lung | Primary cancer | 2,537 | Fibroblast | 40.1% | 0.83 | 0.45 |
| NSCLC_38242124__IMC__88_C4,6 | Lung | Primary cancer | 2,515 | Tumor/Malignant cell | 63.5% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__88_C4,7 | Lung | Primary cancer | 118 | Tumor/Malignant cell | 62.7% | 0.74 | 0.49 |
| NSCLC_38242124__IMC__88_C4,8 | Lung | Primary cancer | 2,727 | Tumor/Malignant cell | 50.8% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__88_C4,9 | Lung | Primary cancer | 2,389 | B cell | 34.6% | 0.64 | 0.64 |
| NSCLC_38242124__IMC__88_C5,1 | Lung | Primary cancer | 3,087 | Fibroblast | 42.9% | 0.81 | 0.49 |